MindBio Therapeutics (XCNQ:MBIO) Ending Cash Position : C$0.22 Mil (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is MindBio Therapeutics Ending Cash Position?

MindBio Therapeutics's Ending Cash Position for the quarter that ended in Mar. 2024 was C$0.22 Mil.

MindBio Therapeutics's quarterly Ending Cash Position declined from Sep. 2023 (C$0.20 Mil) to Dec. 2023 (C$0.09 Mil) but then increased from Dec. 2023 (C$0.09 Mil) to Mar. 2024 (C$0.22 Mil).

MindBio Therapeutics's annual Ending Cash Position increased from Jun. 2021 (C$0.00 Mil) to Jun. 2022 (C$1.18 Mil) but then declined from Jun. 2022 (C$1.18 Mil) to Jun. 2023 (C$0.28 Mil).

MindBio Therapeutics Ending Cash Position Historical Data

The historical data trend for MindBio Therapeutics's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MindBio Therapeutics Ending Cash Position Chart

MindBio Therapeutics Annual Data

Trend

Jun21

Jun22

Jun23

Ending Cash Position

1.18

0.28

MindBio Therapeutics Quarterly Data
	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial					0.17	0.28	0.20	0.09	0.22

MindBio Therapeutics Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

MindBio Therapeutics's Ending Cash Position for the fiscal year that ended in Jun. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	1.171	+	-0.887
	=	0.28

MindBio Therapeutics's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	0.09	+	0.127
	=	0.22

MindBio Therapeutics Ending Cash Position Related Terms

Thank you for viewing the detailed overview of MindBio Therapeutics's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

MindBio Therapeutics (XCNQ:MBIO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MindBio Therapeutics Corp (XCNQ:MBIO) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

WF6:Germany

Address

91-97 William Street, Level 4, Melbourne, VIC, AUS, 3000

Website

https://www.mindbiotherapeutics.com

MindBio Therapeutics Corp is pioneering clinical studies into the microdosing of psychedelic medicines to treat a range of medical conditions such as depression, anxiety, PTSD, panic disorder, chronic pain and opiate addictions. Its clinical trials microdosing of psychedelic medicines provide hope for sufferers of mental health conditions with new emerging treatment alternatives. The company invests in clinical research to discover potential new treatment options and aims to create novel medicines and treatment regimes from breakthrough microdosing studies. Geographically, the activities of the company takes place in Australia.